EP1451210A4 - Hepta-, octa- and nonapeptides having antiangiogenic activity - Google Patents
Hepta-, octa- and nonapeptides having antiangiogenic activityInfo
- Publication number
- EP1451210A4 EP1451210A4 EP02789330A EP02789330A EP1451210A4 EP 1451210 A4 EP1451210 A4 EP 1451210A4 EP 02789330 A EP02789330 A EP 02789330A EP 02789330 A EP02789330 A EP 02789330A EP 1451210 A4 EP1451210 A4 EP 1451210A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- nonapeptides
- hepta
- octa
- antiangiogenic activity
- antiangiogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK10153271.1T DK2177530T3 (en) | 2001-10-31 | 2002-10-30 | Octapeptide with antiangiogenic effect |
EP10153271A EP2177530B1 (en) | 2001-10-31 | 2002-10-30 | Octapeptide having antiangiogenic activity |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US263812 | 1988-10-28 | ||
US10/000,681 US20030125259A1 (en) | 2001-10-31 | 2001-10-31 | Octa- and nonapeptides having antiangiogenic activity |
US681 | 2001-10-31 | ||
US10/263,812 US20030096758A1 (en) | 2001-10-31 | 2002-10-04 | HEPTA-, OCTA- and nonapeptides having antiangiogenic activity |
PCT/US2002/034811 WO2003037268A2 (en) | 2001-10-31 | 2002-10-30 | Hepta-, octa- and nonapeptides having antiangiogenic activity |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1451210A2 EP1451210A2 (en) | 2004-09-01 |
EP1451210A4 true EP1451210A4 (en) | 2009-05-27 |
Family
ID=26667985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02789330A Withdrawn EP1451210A4 (en) | 2001-10-31 | 2002-10-30 | Hepta-, octa- and nonapeptides having antiangiogenic activity |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1451210A4 (en) |
JP (1) | JP4362064B2 (en) |
CN (1) | CN1639188A (en) |
BR (1) | BR0209758A (en) |
CA (1) | CA2466170C (en) |
IL (1) | IL161527A0 (en) |
MX (1) | MXPA04004131A (en) |
NZ (1) | NZ532367A (en) |
PL (1) | PL374238A1 (en) |
TW (1) | TWI268934B (en) |
WO (1) | WO2003037268A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932545A (en) * | 1997-03-17 | 1999-08-03 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
WO1999057149A2 (en) * | 1998-05-05 | 1999-11-11 | Adherex Technologies, Inc. | Compounds and methods for modulating nonclassical cadherin-mediated functions |
WO1999061476A1 (en) * | 1998-05-22 | 1999-12-02 | Abbott Laboratories | Peptide antiangiogenic drugs |
-
2002
- 2002-10-30 PL PL02374238A patent/PL374238A1/en not_active Application Discontinuation
- 2002-10-30 JP JP2003539614A patent/JP4362064B2/en not_active Expired - Fee Related
- 2002-10-30 TW TW091132159A patent/TWI268934B/en not_active IP Right Cessation
- 2002-10-30 CA CA2466170A patent/CA2466170C/en not_active Expired - Fee Related
- 2002-10-30 IL IL16152702A patent/IL161527A0/en unknown
- 2002-10-30 EP EP02789330A patent/EP1451210A4/en not_active Withdrawn
- 2002-10-30 WO PCT/US2002/034811 patent/WO2003037268A2/en active IP Right Grant
- 2002-10-30 BR BR0209758-3A patent/BR0209758A/en not_active IP Right Cessation
- 2002-10-30 CN CNA028258991A patent/CN1639188A/en active Pending
- 2002-10-30 MX MXPA04004131A patent/MXPA04004131A/en active IP Right Grant
- 2002-10-30 NZ NZ532367A patent/NZ532367A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932545A (en) * | 1997-03-17 | 1999-08-03 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
WO1999057149A2 (en) * | 1998-05-05 | 1999-11-11 | Adherex Technologies, Inc. | Compounds and methods for modulating nonclassical cadherin-mediated functions |
WO1999061476A1 (en) * | 1998-05-22 | 1999-12-02 | Abbott Laboratories | Peptide antiangiogenic drugs |
Also Published As
Publication number | Publication date |
---|---|
TWI268934B (en) | 2006-12-21 |
CN1639188A (en) | 2005-07-13 |
IL161527A0 (en) | 2004-09-27 |
JP4362064B2 (en) | 2009-11-11 |
EP1451210A2 (en) | 2004-09-01 |
TW200302832A (en) | 2003-08-16 |
NZ532367A (en) | 2006-01-27 |
CA2466170C (en) | 2011-04-05 |
BR0209758A (en) | 2005-10-04 |
PL374238A1 (en) | 2005-10-03 |
WO2003037268A3 (en) | 2003-09-12 |
JP2005512981A (en) | 2005-05-12 |
CA2466170A1 (en) | 2003-05-08 |
WO2003037268A2 (en) | 2003-05-08 |
MXPA04004131A (en) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0119327D0 (en) | Catalyst | |
GB0102902D0 (en) | Medicaments | |
PL368745A1 (en) | Peptides having antiangiogenic activity | |
GB2383410B (en) | Joystick | |
IL161527A0 (en) | Hepta-, octa-and nonapeptides having antiangiogenic activity | |
SG100673A1 (en) | Arrangement for abacus-like calculation | |
GB0130217D0 (en) | Hand guard | |
ZA200403242B (en) | Hepta-, Octa- and Nonapeptides having antianglogenic activity. | |
GB0105469D0 (en) | Medicaments | |
EP1471804A4 (en) | Clearvision ridesafe glove | |
TW472634U (en) | Gantry type machining center | |
EP1461356A4 (en) | Hexa-, hepta-, and octapeptides having antiangiogenic activity | |
GB2379860B (en) | Glove | |
DE60133138D1 (en) | (-)-olivil als antioxidationsmittel | |
AU2002315383A1 (en) | Peptides having antiangiogenic activity | |
EP1451209A4 (en) | Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity | |
GB0117037D0 (en) | Catalyst | |
GB0115182D0 (en) | Medicaments | |
GB0106027D0 (en) | Concept seven | |
GB0112189D0 (en) | Concept three | |
GB0108043D0 (en) | Glove | |
GB0121348D0 (en) | Kiddi guard (m) | |
GB0115582D0 (en) | Scalpel | |
GB0105542D0 (en) | Catalyst | |
GB0121344D0 (en) | Kiddi guard |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040528 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1071146 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090424 |
|
17Q | First examination report despatched |
Effective date: 20090817 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100303 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1071146 Country of ref document: HK |